The pharmacokinetic profile of a biodegradable controlled-release delivery system containing doxycycline compared to systemically delivered doxycycline in gingival crevicular fluid, saliva, and serum

Journal of Periodontology

Volumn 69, Issue 10, 1998, Pages 1085-1091

  Stoller, Norman H ^a,c   Johnson, Lonnie R ^a   Trapnell, Sheri ^a   Harrold, Charles Q ^a   Garrett, Steve ^b  

^a UNIVERSITY OF COLORADO SCHOOL OF DENTAL MEDICINE   (United States)

^b QLT Inc   (United States)

^c UNIVERSITY OF COLORADO   (United States)

Author keywords

Doxycycline pharmacokinetics doxycycline hyclate; Drug delivery systems, biodegradable; Periodontal pockets drug therapy

Indexed keywords

CYANOACRYLATE DERIVATIVE; DOXYCYCLINE; EUGENOL;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG SALIVA LEVEL; FEMALE; GINGIVA; GINGIVITIS; HUMAN; MALE; PERIODONTITIS; RANDOMIZED CONTROLLED TRIAL;

EID: 0031792083     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.1998.69.10.1085     Document Type: Article

References (18)

1. Drisko CH. Non-surgical pocket therapy: Pharmacotherapeutics. Ann Periodontol 1996;1:491-566.
2. Oosterwaal PJM, Mikx FHM, Renggli HH. Clearance of a topically applied fluorescein gel from periodontal pockets. J Clin Periodontol 1990;17:613-615.
3. Goodson JM, Holborow D, Dunn RL, et al. Monolithic tetracycline-containing fibers for controlled delivery to periodontal pockets. J Periodontol 1983;54:575-579.
4. Tonetti M, Cugini MA, Goodson JM. Zero-order delivery with periodontal placement of tetracycline-loaded ethylene vinyl acetate fibers. J Periodont Res 1990;25:243-249.
5. Rapley JW, Cobb CM, Killoy WJ, et al. Serum levels of tetracycline during treatment with tetracycline containing fibers. J Periodontol 1992;63:817-820.
6. Polson AM, Garrett S, Stoller NH, et al. Multi-center comparative evaluation of subgingivally delivered sanguinarine and doxycycline in the treatment of periodontitis. I. Study design, procedures, and management. J Periodontol 1997;68:110-118.
7. Pascale D, Gordon JM, Lamster I, et al. Concentration of doxycycline in human gingival fluid. J Clin Periodontol 1986;13:841-844.
8. Gordon JM, Walker CB, Goodson JM, et al. Sensitive assay for measuring tetracycline levels in gingival crevice fluid. Antimicrob Agents Chemotherapy 1980;17:193-198.
9. Gordon JM, Walker CB, Murphy JC, et al. Tetracycline: Levels achievable in gingival crevice fluid and in vitro effect on subgingival organisms. Part I. Concentrations in crevicular fluid after repeated doses. J Periodontol 1981;52:609-612.
10. Gordon JM, Walker CB, Murphy JC. Concentration of tetracycline in gingival fluid after single doses. J Clin Periodontol 1981:8:117-121.
11. Ciancio SG, Mather ML, McMullen JA. An evaluation of minocycline in patients with periodontal disease. J Periodontol 1980;51: 530-534.
12. Walker CB, Gordon JM, Cornwall HA, et al. Gingival crevicular fluid levels of clindamycin compared to its minimal inhibitory concentrations for periodontal bacteria. Antimicrob Agents Chemotherapy 1981;19:862-871.
13. Layton JM, Walker CB, Pappas JD. Gingival fluid levels of amoxicillin and its MICs for periodontal bacteria. J Dent Res 1983;62 (Spec. Issue):290(Abstr. 1086).
14. Takada K, Hirasawa M and Ikeda T. Isolation and purification of bacteriocin from Prevotella intermedia. J Periodontol 1991;62:439-444.
15. Cimasoni G. Crevicular Fluid Updated Basel: Karger; 1983:72-74.
16. Maze GI, Reinhardt RA, Payne JB, et al. Gingival fluid tetracycline release from bioerodible gels. J Clin Periodontol 1996;23:1133-1136.
17. Slots J, Rams TE. Antibiotics in periodontal therapy: advantages and disadvantages. J Clin Periodontol 1990;17:479-493.
18. Garrett S, Adams D, Bandt C, et al. Two multi-center clinical trials of subgingival doxycycline in the treatment of periodontitis. J Dent Res 1997:76 (Spec. Issue):153(Abstr. 1113).